Effect of procathepsin D and its activation peptide on prostate cancer cells

Cancer Letters

Volumn 129, Issue 1, 1998, Pages 55-59

  Vetvicka, Vaclav ^a   Vetvickova, Jana ^a   Fusek, Martin ^b  

^a University of Louisville School of Medicine   (United States)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Activation peptide; Growth factors; Procathepsin D; Proliferation; Prostate cancer

Indexed keywords

CATHEPSIN D; PROTEIN PRECURSOR; SYNTHETIC PEPTIDE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

CATHEPSIN D; CELL DIVISION; CELL LINE; ENZYME PRECURSORS; HUMANS; MALE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032479520     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00091-3     Document Type: Article

References (23)

1. Allgayer H., Babic R., Grützner K.U., Beyer B.C.M., Tarabichi A., Schildberg F.W., Heiss M.M. An immunohistochemical assessment of cathepsin D in gastric carcinoma - Its impact on clinical prognosis. Cancer. 80:1997;179-187.
2. Athanassiadou P., Sakellariou V., Michalas S., Petrakakou E., Athanassiades P., Aravantinos D. Immunocytochemical localization of cathepsin D and CA 125 in ovarian cancer. Int. J. Gynecol. Obstet. 56:1997;31-37.
3. Cavailles V., Augreau P., Rochefort H. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc. Natl. Acad. Sci. USA. 90:1993;203-207.
4. Chambon M., Rebillard X., Rochefort H., Brouillet J.P., Baldet P., Guiter J., Maudelonde T. Cathepsin D cytosolic assay and immunohistochemical quantification in human prostate tumors. Prostate. 24:1994;320-325.
5. Conover C.A., Perry J.E., Tindall D.J. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J. Clin. Endocrinol. Metab. 80:1995;987-993.
6. Ferrandina G., Scambia G., Panici P., Alamdori G., Paludetti G., Cadoni G., Distefano M., Maurizi M., Mancuso S. Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor status. Cancer Lett. 67:1992;133-138.
7. Fusek M., Vetvicka V. Mitogenic function of human procathepsin D - role of the activation peptide. Biochem. J. 303:1994;775-780.
8. Hoosein N.M., Logothetis C.J., Chung L.W. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J. Urol. 149:1993;1209-1213.
9. Huet G., Zerimech F., Dieu M.C., Hemon B., Grard G., Balduyck M., Janin A., Lafyatis R., Degand P. The state of differentiation of HT-29 colon carcinoma cells alters the secretion of cathepsin D and of plasminogen activator. Int. J. Cancer. 57:1994;875-882.
10. Joensuu H., Toikkanen S., Isola J. Stromal cell cathepsin D expression and long-term survival in breast cancer. Br. J. Cancer. 71:1995;155-159.
11. Koelsch G., Mares M., Metcalf P., Fusek M. Multiple function of pro-parts of aspartic proteinase zymogens. FEBS Lett. 343:1994;6-10.
12. Kornfeld S., Mellman I. The biogenesis of lysosomes. Annu. Rev. Cell Biol. 5:1989;483-525.
13. Makar R., Mason A., Kittelson J.M., Bowden G.T., Cress A.E., Nagle R.B. Immunohistochemical analysis of cathepsin D in prostate carcinoma. Mod. Pathol. 7:1994;747-751.
14. Nazeer T., Malfetano J.H., Rosano T.G., Ross J.S. Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma. J. Clin. Pathol. 97:1992;764-769.
15. Rochefort H. Biological and clinical significance of cathepsin D in breast cancer. Acta Oncol. 31:1992;125-130.
16. Stewart A.J., Piggott N.H., May F.E.B., Westley B.R. Mitogenic activity of procathepsin D purified from conditioned medium of breast-cancer cells by affinity chromatography on pepstatinyl agarose. Int. J. Cancer. 57:1994;715-718.
17. Theodorescu D., Broder S.R., Boyd J.C., Mills S.E., Frierson H.F. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer. 80:1997;2109-2119.
18. Valentini A.M., Pirrelli M., Armentano R., Caruso M.L. The immunohistochemical expression of cathepsin D in colorectal cancer. Anticancer Res. 16:1996;77-80.
19. Vetvicka V., Vetvickova J., Fusek M. Effect of human procathepsin D on proliferation of human cell lines. Cancer Lett. 79:1994;131-135.
20. Vetvicka V., Vetvickova J., Fusek M. Participation of the propeptide on procathepsin D activation of human peripheral lymphocytes and neutrophils. Arch. Biochem. Biophys. 322(1):1995;295-298.
21. Vetvicka V., Vetvickova J., Hilgert I., Voburka Z., Fusek M. Analysis of the interaction of procathepsin D activation peptide with breast cancer cells. Int. J. Cancer. 73:1997;403-409.
22. Vignon F., Capony F., Chambon M., Freiss G., Garcia M., Rochefort H. Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology. 118:1986;1537-1545.
23. Westley B., Rochefort H. A secretion of glycoprotein induced by estrogens in human breast cancer cell lines. Cell. 20:1980;352-362.